Hi

HIGH COST DRUGS (OPCS)
HIGH RISK WOMEN INVITED FOR SCREENING IN PERIOD TOTAL
HIGH RISK WOMEN SCREENED TOTAL (TECHNICALLY ADEQUATE)
HIP MEASUREMENT
HIP SURGERY PATIENT POSITION
HISTOLOGY CONFIRMED NECROTISING ENTEROCOLITIS FOLLOWING LAPAROTOMY INDICATOR
HOLISTIC NEEDS ASSESSMENT COMPLETED DATE
HOLISTIC NEEDS ASSESSMENT POINT OF PATHWAY (CANCER)
HORMONE EXPRESSION TYPE
HOSPITAL PROVIDER SPELL NUMBER
ISO 9001 CERTIFICATION EUROPE